The MOH further announced plans to release a list of over 100 disease categories that will be covered by the clinical pathway management system and to promote the system in all level three hospitals nationwide. The clinical pathway system may be an important...
Novo Nordisk revealed last week that its recently-announced Beijing (diabetes) R&D center expansion has a budget of USD 100 million – with up to USD 40 million earmarked for new labs that should be operational by the end of 2011. Novo also released results...
In China, many life science companies are located in science parks which are found in many major cities, such as Shanghai, Beijing, Tianjin, Nanjing, and Suzhou. The largest science park in China where most Western pharmaceutical companies are located is in Z-BASE, in...
The new list contains 174 products which will have their maximum retail price reduced, as well as 16 products which will no longer receive separate pricing status and have been demoted to general pricing. The average price reduction is reported to be 19%. Of the items...
Consolidation continues at a brisk pace in the drug distribution sector, with Shanghai Pharma and Sinopharm, among others, buying regional distributors left and right. US distribution giant Cardinal Health has also jumped into the game, announcing the acquisition of...